T. Matsuzaki

发表

Localized scleroderma associated with progressing ischemic stroke

N. Kanzato, T. Matsuzaki, Y. Komine, 1999, Journal of the Neurological Sciences.

HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: Analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years

S. Akiba, K. Arimura, M. Nakagawa, 2001, Journal of NeuroVirology.

The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis

Yuetsu Tanaka, H. Ushirogawa, E. Matsuura, 2017, Virology Journal.

HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors

M. Matsuoka, Y. Yamano, H. Takashima, 2015, Journal of NeuroVirology.

Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.

Yuetsu Tanaka, S. Izumo, H. Takashima, 2011, The Journal of infectious diseases.

A novel MPZ gene mutation in dominantly inherited neuropathy with focally folded myelin sheaths

S. Sakoda, M. Nakagawa, S. Izumo, 1999, Neurology.

Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis

A. Utsunomiya, E. Matsuura, S. Izumo, 2020, PLoS neglected tropical diseases.

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

E. Matsuura, S. Izumo, H. Takashima, 2014, PloS one.

Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders.

M. Nomoto, M. Osame, Y. Yoshida, 1999, Internal medicine.

Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.

M. Nakagawa, S. Izumo, M. Nagai, 2004, The Journal of infectious diseases.

HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.

S. Akiba, K. Arimura, M. Nakagawa, 2000, Journal of neurovirology.

Germline mosaicism of MPZ Gene in Dejerine-Sottas syndrome (HMSN III) associated with hereditary stomatocytosis

M. Nakagawa, S. Izumo, H. Takashima, 1999, Neuromuscular Disorders.

Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

Yuetsu Tanaka, H. Takashima, T. Matsuzaki, 2017, Virology Journal.

Gene for hereditary motor and sensory neuropathy (proximal dominant form) mapped to 3q13.1

J. Terwilliger, M. Nakagawa, H. Takashima, 1999, Neuromuscular Disorders.

Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis

Yuetsu Tanaka, S. Izumo, H. Takashima, 2013, Retrovirology.

Macrophage-dominant sialadenitis in human T-cell leukemia virus type I-associated myelopathy after living-donor liver transplantation.

S. Yamasaki, T. Hayashi, K. Eguchi, 2010, Transplantation proceedings.

Facioscapulohumeral muscular dystrophy: clinical diversity and genetic abnormalities in Japanese patients.

K. Arimura, M. Nakagawa, M. Osame, 1997, Internal medicine.

Flow cytometry evaluation of the T-cell receptor Vβ repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: Effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

K. Arimura, S. Izumo, M. Osame, 2006, Journal of the Neurological Sciences.

Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: Application of best-fit logistic regression equation based on host genotype, age, and provirus load

K. Arimura, S. Izumo, M. Osame, 2006, Journal of NeuroVirology.

Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

E. Matsuura, S. Izumo, H. Takashima, 2021, Journal of Clinical Microbiology.

Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status

Yuetsu Tanaka, H. Takashima, T. Matsuzaki, 2016, Retrovirology.

Isokinetic trunk and knee muscle strengths and gait performance in walking patients with T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP).

M. Miyazaki, Y. Yoshida, T. Matsuzaki, 2011, Journal of the Japanese Physical Therapy Association = Rigaku ryoho.

Diseases among men living in human T-lymphotropic virus type I endemic areas in Japan.

K. Arimura, M. Osame, T. Matsuzaki, 1993, Internal medicine.

A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis

K. Arimura, S. Izumo, M. Osame, 2005, Journal of the Neurological Sciences.

Atypical rigid form of Huntington's disease: a case with peripheral amyotrophy and congenital defects of a lower limb.

M. Nakagawa, N. Kanzato, T. Matsuzaki, 1998, Internal medicine.

Phenotypic variation in a large Japanese family with Miyoshi myopathy with nonsense mutation in exon 19 of dysferlin gene

M. Nakagawa, H. Takashima, K. Goto, 2001, Journal of the Neurological Sciences.

A new type of hereditary motor and sensory neuropathy linked to chromosome 3

K. Arimura, M. Nakagawa, S. Izumo, 1997, Annals of neurology.

In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Kousuke Saito, M. Matsuoka, J. Yasunaga, 2009, Retrovirology.

Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status

Yuetsu Tanaka, H. Takashima, T. Matsuzaki, 2016, Retrovirology.

M. Matsuoka, Y. Yamano, H. Takashima, 2016, Journal of NeuroVirology.

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial

H. Sasaki, K. Satoh, Hideki Nakamura, 2013, BMC Medicine.

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic

S. Izumo, H. Takashima, R. Kubota, 2014, Retrovirology.

The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice

Yuetsu Tanaka, H. Takashima, H. Fujii, 2014, Retrovirology.

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis

E. Matsuura, S. Izumo, H. Takashima, 2017, Retrovirology.

Efficacy of l‐Arginine treatment in patients with HTLV‐1‐associated neurological disease

E. Matsuura, Y. Yamano, H. Takashima, 2022, Annals of clinical and translational neurology.

Identification and tracking of HTLV-1–infected T cell clones in virus-associated neurologic disease

S. Nakahata, H. Takashima, A. Yoshimura, 2023, JCI insight.

Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

Yuetsu Tanaka, H. Takashima, T. Matsuzaki, 2017, Virology Journal.

Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study

E. Inoue, N. Araya, M. Nakagawa, 2017, Neurotherapeutics.

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis

J. Kira, H. Yonezawa, Takahiko Ueno, 2020, Orphanet Journal of Rare Diseases.

Yuetsu Tanaka, H. Ushirogawa, E. Matsuura, 2017, Virology Journal.

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis

E. Matsuura, S. Izumo, H. Takashima, 2017, Retrovirology.

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

E. Matsuura, S. Izumo, H. Takashima, 2014, PloS one.